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Three nanostructured vehicles are proposed as potential carriers for photosensitizers to be used in
photodynamic therapy: spherical nanoparticles, hexahedral microparticles and cylindrical magnetic
nanorods. A comparative study of their photodynamic properties was performed, and the inﬂuence of
their size and the amount of loaded porphyrin was considered to discuss their eﬀects in the observed
photodynamic activity. All the vehicles have a gold surface, allowing functionalization with a disulﬁde-
containing porphyrin as the photosensitizer, as well as with a PEG-containing thiol to improve their
biocompatibility and water solubility. The activity of the porphyrin loaded in each vehicle was assessed
through in vitro photocytotoxicity studies using HeLa cells. A synergic eﬀect for the porphyrin toxicity
was observed in all of the vehicles. The zinc-containing porphyrin showed better production of singlet
oxygen, and proved more photocytotoxic both in solution and loaded in any of the vehicles. The
magnetism of the nanorods allows targeting with a magnetic ﬁeld, but causes their aggregation,
hampering the porphyrin's activity. Microparticles showed lower cell internalization but their bigger size
allowed a high porphyrin loading, which translated into high photocytotoxicity. The highest cell
internalization and photocytotoxicity was observed for the porphyrin-loaded nanoparticles, suggesting
that a smaller size is favored in cell uptake.Introduction
Photodynamic therapy (PDT) is a treatment used in cancer
therapy and requires a photosensitizer (PS) molecule, nontoxic
in the dark, that when irradiated with visible or near-infrareda i Qu´ımica Terape`utica, Universitat de
arcelona, Spain. E-mail: mlperez@ub.edu
(IN2UB), Universitat de Barcelona, Avda.
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(ESI) available: (1) Synthesis and
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nglet oxygen production, (5) in vitro
nstructions of vehicle uptake by HeLa
e University of Nottingham, University
hemistry 2017light produces molecular singlet oxygen that triggers cellular
death.1–4 Most PSs investigated for PDT applications are chlor-
ins,5,6 bacteriochlorins,7 phthalocyanines8,9 and, especially,
porphyrins.10–12
PDT presents several advantages: it is less invasive, has fewer
secondary eﬀects, and allows more localized treatment.
However, some of the major drawbacks of some PSs when used
in PDT are the non-specic distribution of the drug in the body
as well as the slow excretion of the photosensitizer, leading to
severe side eﬀects caused by the patient's exposure to sunlight.
Furthermore, some of the currently used PSs are hydrophobic
molecules, requiring their dispersion in emulsions or the use of
delivery systems to administer the drugs to the biological
media. Therefore, the use of nanostructured vehicles to trans-
port and deliver such PSs to the desired target can help to
overcome this limitation.13 Some examples already described in
literature include iron oxide nanoparticles,14,15 silica nano-
particles,16,17 polymeric nanoparticles,18,19 scintillating nano-
particles,20 magnetic nanoparticles,14,18,21 gold nanowires,22
upconverting nanoparticles6,23 and gold nanoparticles
(GNP)6,24–27 as drug delivery systems.
Among these alternatives, research using GNP is very wide-
spread due to their inertness, relatively low toxicity, and facile
synthesis and functionalization,24,28–30 thus allowing theirRSC Adv., 2017, 7, 16963–16976 | 16963
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View Article Onlinetailoring to target cancer cells, increasing the selectivity of the
photosensitizer-vehicle system, and decreasing undesired side
eﬀects. Such systems composed of antibody-photosensitizer-
GNP have showed promising results.31,32
Although functionalization of GNP is easy, the conjugation
of more than one molecule implies a more complicated proce-
dure. One alternative is the use of Janus type particles,33 with
diﬀerent materials that may allow orthogonal chemical func-
tionalization, facilitating the process of immobilizing diﬀerent
functional molecules on the same vehicle. Diﬀerent alternatives
can be used for targeting, as for example using magnetic
particles to direct the vehicles to the cancerous tissue through
applying amagnetic eld, thusmoving the particles towards the
correct site of action.34 This approach has been described for
magnetic active targeting of cancer cells using magnetic nano-
particles associated with mesoporous silica nanoparticles35 or
micro/nanospheres.36 Superparamagnetic iron oxide nano-
particles have also been used to cross the blood–brain barrier in
order to treat glioma.37 One of the key aspects of a vehicle is its
size and shape. It was already described that hexahedral silicon
oxide microparticles can be easily internalized in HeLa cells.38
Furthermore, silica semi-spheres with diameters of 1.6 and 3.2
mm can be internalized in endothelial cells.39 Gold nano-
particles with diﬀerent sizes and aspect ratios have been
described to have a better uptake by HeLa cells when the aspect
ratio is lower,40,41 but other nanoparticles with diﬀerent aspect
ratios showed a diﬀerent trend, with a better uptake found for
high aspect ratio,42,43 as well as higher internalization rate in the
cells. This is explained by the fact that the internalization
mechanism appears to depend on the aspect ratio: spherical
particles are internalized by clathrin-mediated pathway prefer-
ably, while particles with larger aspect ratios tend to internalize
by caveolae-mediated pathway.44 Therefore, literature suggests
that not only the size and shape, but also the composition of the
used nanomaterial has inuence on the uptake of vehicles into
cells, but a clear tendency is not yet well established.
The aim of this work is to study three diﬀerent types of
vehicles as carriers for two disulde-bearing amidoporphyrins.
We select three kinds of carriers for PDT, all presenting a gold
surface to favour an easy functionalization with the PS. Each
one of these carriers presents a specic characteristic that could
be interesting to enhance the eﬃciency of the PS on PDT:
(1) GNP, widely studied as drug delivery carriers,28,45 have
a diameter of few nanometers and should be easily internalized
into the cells,
(2) Cobalt–nickel nanorods (NR) with a gold shell and
a magnetic core, that have recently been reported to be
biocompatible46 and useful as drug delivery vehicles,47 are easily
manipulable and can be targeted by means of a magnetic eld,
and
(3) Hexahedral Janus microparticles (mP) with two diﬀerent
materials (gold and polysilicon) to allow orthogonal function-
alization, and that recently have been reported to be biocom-
patible and internalized by SK-BR-3 and MCF-10A cell lines.48,49
The gold surface present in all the vehicles allows the
immobilization of the disulde-bearing amidoporphyrins.
Therefore we describe the synthesis and characterization of two16964 | RSC Adv., 2017, 7, 16963–16976new amidoderivatives of an aminophenylporphyrin and its Zn
analogue using lipoic acid (LA) as linker, their conjugation to
the three above-mentioned gold-based vehicles, the physico-
chemical characterization of the porphyrin-loaded vehicles
through diﬀerent techniques, and their PDT activity, in terms of
the singlet oxygen production, as well as their photocytotoxicity
and cellular uptake using HeLa cells, in order to select the
optimal delivery vehicle for use in PDT.Experimental
Materials
Solvents. Propionic acid, dimethylformamide (DMF),
dichloromethane (DCM), methanol (MeOH), chloroform
(CHCl3) and dimethyl sulfoxide (DMSO) were purchased from
Sigma-Aldrich (Germany).
Reagents. Hydroxybenzotriazole monohydrate (HOBT), 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide,
9,10-anthracenediyl-bis(methylene)dimalonic acid (ABMA),
(11-mercaptoundecyl)hexa(ethylene glycol) (MHEG), glacial
acetic acid, ammonium hydroxide (20%), benzaldehyde, lipoic
acid (LA), nitric acid (HNO3), potassium bromide (KBr), pyrrole,
sodium bicarbonate, sodium sulfate, tin(II) chloride dihydrate
(SnCl2$2H2O), trichloroacetic acid, zinc acetate dihydrate
(Zn(OAc)2$2H2O) and sodium borohydride (NaBH4), were
purchased from Sigma Aldrich (Germany), (6-{2-[2-(2-methox-
yethoxy)ethoxy]ethoxy}hexyl)trimethoxysilane (MTMS) was
purchased from Sikemia (France), sodium hydroxide (97%,
pellets) and dicyclohexylcarbodiimide (DCC) were purchased
from Merck (Germany), hydrochloric acid 6N and sulfuric acid
(97%) were purchased from Scharlab (Spain). Dulbecco's
Modied Eagle Medium (DMEM) fetal bovine serum (FBS),
glucose, L-glutamine, streptomycin sulfate and potassium
penicillin were purchased from Gibco-Life Technologies (UK).Characterization methods
Melting points were measured by CTP-MP 300 hot-plate appa-
ratus with ASTM 2C thermometer using crystal capillaries
purchased from Afora. 1H-NMR spectra were recorded on
a Varian Gemini 300 spectrometer (300 MHz) and on a Varian
Mercury 400 spectrometer (400 MHz) from Centres Cientics i
Tecnolo`gics de la Universitat de Barcelona (CCiT-UB). 1H-NMR
spectra were determined using CDCl3 as solvent with TMS
(tetramethylsilane) as internal standard. The chemical shis
are expressed in parts per million (ppm) relative to the central
peak of the solvent. Matrix Assisted Laser Desorption
Ionization-Time of Flight Mass Spectrometry (MALDI-ToF-MS)
analyses were performed using a Voyager-DE-RP mass spec-
trometer (Applied Biosystem, Framingham, USA) and high
resolution mass spectra (HRMS) were obtained by electrospray
(ESI) on a LC/MSD-ToF mass spectrometer (Agilent Technolo-
gies, 2006) from CCiT-UB. MS analysis was operated in the
delayed extractionmode using 2,5-dihydroxybenzoic acid (DHB)
as a matrix. Thin layer chromatography (TLC) was performed on
Merck silica gel plates coated with F254 uorescent indicator.
Column chromatography was carried out on silica gel 60 (MerckThis journal is © The Royal Society of Chemistry 2017
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View Article Online9385, 230-400 mesh). Elemental analysis was performed on
a Thermo EA 1108 CHNS from CCiT-UB. UV-visible absorption
spectra were obtained using an UV-1800 Shimadzu UV spec-
trophotometer, using quartz cuvettes with a 1 cm path length.
Absorption spectra were determined in CHCl3 or water. In
general, the compounds were dried overnight at 25 C in
a desiccator. Fluorescence excitation and emission spectra were
recorded using a Hitachi F-4500 uorescence spectrometer. The
spectra were recorded in right angle using quartz cuvettes with
a 1 cm path length. Transmission electron microscopy (TEM)
was carried out in the CCiT-UB. The samples were observed with
an electronic microscope Tecnai SPIRIT (FEI Co) at 120 kV. The
images were captured by a Megaview III camera and digitalized
with the iTEM program. The size of the gold nanoparticles core
was measured with the Analysis soware (Olympus). The size of
the nanoparticles was also determined by Dynamic Light Scat-
tering (DLS) using a Zetasizer Nano ZS series (Malvern Instru-
ments). Thermogravimetric analysis (TGA) was recorded with
a SDT Q600 TA Instrument under N2 atmosphere (N2 ow: 50
mL min1). The scanning rate was 5 C min1 and the
temperature range was between 70 and 600 C for each sample.
Electrochemical experiments have been performed by using
a Potentiostat/Galvanostat Autolab PSTAT30, controlled by the
GPES program. Cell concentration was calculated using a Luna
Automated Cell Counter. Absorbance measurements on
microplates were obtained using a microplate reader Syn-
ergyMx™ (BioTek Instruments, Inc.). HeLa cells were imaged by
confocal microscopy using a Leica TCS SP2 confocal laser
uorescence microscope (Leica, Heidelberg, Germany) from
CCiT-UB, with simultaneously uorescence and reection
acquisition, by using an argon laser of 488 nm.Synthesis of ATPP-LA1 and ATPP-LA
The synthesis of the precursors of porphyrins ATPP-LA and
ZnATPP-LA (TPP, TPPNO2, TPPNH2, ZnTPPNH2) are explained
in detail in the ESI.†
Hydroxybenzotriazole monohydrate (91 mg, 0.68 mmol) and
dicyclohexylcarbodiimide (70 mg, 0.34 mmol) were added to
a solution of lipoic acid (70 mg, 0.34 mmol) in dry DMF. The
solution was cooled down with an ice-water bath and stirred for
1 h. Then a solution of TPPNH2 (108 mg, 0.17 mmol) in 6 mL of
dry DMF was added and the reaction was stirred at room
temperature overnight. Aer this time, the solvent was evapo-
rated in vacuum. The mixture was washed with a saturated
solution of 5% NaHCO3 (50 mL). Then the product was extrac-
ted with CHCl3 (2  50 mL), and the organic layer was washed
with water (2  50 mL) and dried over sodium sulfate anhy-
drous and the organic layer was evaporated under reduced
pressure and the crude product puried by column chroma-
tography (SiO2, DCM) to aﬀord a purple solid (125 mg, 87%):
m.p. 180 C, rf ¼ 0.44 in DCM. UV-vis (DCM) lmax 419, 514, 552,
591, 650 nm. The uorescence emission spectra exhibit two
peaks at 655 and 719 nm (excitation 590 nm). 1H-NMR (400
MHz, CDCl3, 25 C): d ppm ¼ 2.77 (s, 2H, –NH), 1.95–1.55 (m,
8H, 4 (CH2)), 2.29–2.23 (m, 1H, CH), 2.51 (t, J¼ 2.4 Hz, 1H, CH),
2.66–2.60 (m, 1H, CH), 3.60–3.55 (m, 1H, CH), 3.45–3.38 (m, 1H,This journal is © The Royal Society of Chemistry 2017CH), 4.21–4.18 (m, 1H, NH), 7.72–7.74 (m, 3H, Ar-H), 8.13 (dd, J
¼ 6.0 Hz, J¼ 6.0 Hz, 4H, amide phenyl), 8.20 (dd, J¼ 7.0 Hz, J¼
7.0 Hz, 8H, b-pyrrole), 8.85 (s, 12H, Ar-H). MALDI-ToF-MS: m/z
(%) ¼ 850.2 (100) [M]+. HMRS (ESI) m/z: (C52H43N5O3S2) calcu-
lated 849.2800 found 850.2880. Elemental analysis found: N,
8.34; C, 73.42; H, 5.18; S, 7.48. Calc. for C52H43N5O3S2: N, 8.24;
C, 73.47; H, 5.10; S, 7.54%. Then a solution of ATPP-LA1 (25 mg,
0.025 mmol) in DCM (5 mL) was added to a stirred solution of
NaBH4 (7.5 mg, 0.198 mmol) in water (1.0 mL). The mixture was
stirred at room temperature overnight. The phases were sepa-
rated and the organic phase was washed with water (3 50 mL),
then dried over sodium sulfate anhydrous and concentrated
under vacuum to give ATPP-LA as a purple solid (21 mg, 84%).
UV-vis lmax (DCM)/nm 419, 517, 554, 590 and 652. The uo-
rescence emission spectra exhibit two peaks at 652 and 709 nm
(excitation 590 nm). Due to instability of the porphyrin ATPP-LA
which results in its oxidation, ATPP-LA was used in situ in the
functionalization of the three diﬀerent vehicles.
Synthesis of ZnATPP-LA
Hydroxybenzotriazole monohydrate (43 mg, 0.35 mmol) and
dicyclohexylcarbodiimide (36 mg, 0.17 mmol) were added to
a solution of lipoic acid (36 mg, 0.17 mmol) in dry DMF. The
solution was stirred at ice water bath temperature for 1 h. Then
a solution of ZnTPPNH2 (61 mg, 0.08 mmol) in dry DMF (3 mL)
was added. The reaction was stirred at room temperature
overnight. The solvent is evaporated in vacuum. The mixture
was washed with a saturated solution of 5% NaHCO3 (50 mL).
Then the product was extracted with DCM (2  50 mL), and the
organic layer was washed with water (2  50 mL) and dried over
sodium sulfate anhydrous and the organic layer was evaporated
under reduced pressure and the crude product puried by
column chromatography (SiO2, DCM) to aﬀord a purple solid
(69 mg, 93%): m.p. 180 C, rf ¼ 0.40 in DCM. UV-vis (DCM) lmax
420, 541, 588 nm. The uorescence emission spectra exhibit two
peaks at 600 and 650 nm (excitation at 550). 1H-NMR (400 MHz,
CDCl3, 25 C): d ppm ¼ 1.42–1.10 (m, 8H, CH2), 1.57 (t, J ¼
1.2 Hz, 1H, CH), 2.21–2.18 (m, 1H, CH), 1.63–1.60 (m, 1H, CH),
2.79–2.74 (m, 1H, CH), 3.16–3.14 (m, 1H, NH), 2.92–2.88 (m, 1H,
CH), 7.12 (d, J ¼ 3.4 Hz, 2H, amide phenyl), 7.74–7.71 (m, 9H,
Ar-H), 8.00 (d, J ¼ 3.8 Hz, 2H, amide phenyl), 8.22–8.20 (m, 6H,
Ar-H), 8.86 (d, J ¼ 4.2 Hz, 2H, b-pyrrole), 8.92 (d, J ¼ 4.3 Hz, 2H,
b-pyrrole), 8.94 (s, 4H, b-pyrrole). MALDI-ToF-MS: m/z (%) ¼
879.2 (100) [M]+. HMRS (ESI) m/z: (C52H41N5OS2Zn) calculated
879.2000 found 879.2045.
Synthesis and characterization of gold nanoparticles (GNP)
with ATPP-LA (ATPP-LA-GNP) and ZnATPP-LA (ZnATPP-LA-
GNP)
A solution of HAuCl4$3H2O (2.0 mg, 0.005 mmol) in water (1
mL) was added to a stirred solution of ATPP-LA (4.1 mg, 0.005
mmol) in CHCl3 (0.5 mL) or ZnATPP-LA (4.3 mg, 0.005 mmol) in
CH2Cl2 (0.5 mL). The thiol MHEG (2.3 mg, 0.009 mmol) was
dissolved in water (1 mL) and the solution was added to the
mixture under vigorous stirring. An excess of NaBH4 (5.6 mg,
0.148 mmol) or (2.8 mg, 0.074 mmol) in water (1 mL) was addedRSC Adv., 2017, 7, 16963–16976 | 16965
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View Article Onlinedropwise to the corresponding mixture. The stirring continued
for 24 h in the dark at room temperature. GNP were obtained in
aqueous phase. The phases were separated using an extraction
funnel and the solvent of the aqueous phase was removed in
a rotary evaporator, followed by multiple washings with water
and CHCl3 (3  1 mL) using centrifugation (14 000 rpm, 17 min
at 15 C). The water-soluble GNP containing the porphyrin
ATPP-LA were named as ATPP-LA-GNP and the GNP containing
the porphyrin ZnATPP-LA were named as ATPP-LA-GNP.
Functionalization of nanorods (NR)
The nanorods (NR) used in this study were obtained as
described elsewhere,46 and are composed of a magnetic core
made of cobalt and nickel covered by a gold shell. Three
diﬀerent NR-based samples were prepared: a control sample
containing MHEG-functionalized NR (PEG-NR), a sample with
MHEG and ATPP-LA (ATPP-LA-NR), and a sample with MHEG
and ZnATPP-LA (ZnATPP-LA-NR). The functionalization was
performed as follows: for the preparation of the control sample
PEG-NR, 200 mM of MHEG in DMSO (1 mL) was added to a vial
containing 450 mg of dry NR; for the preparation of ATPP-LA-NR
and ZnATPP-LA-NR samples, 1 mL of a solution containing 200
mM of MHEG and 20 mM of porphyrin ATPP-LA or ZnATPP-LA in
DMSO was added, respectively to a vial containing 450 mg of dry
NR. For characterization purpose, control NR identied as NR-
H and NR-Zn, containing the porphyrin ATPP-LA or ZnATPP-LA
respectively, but no PEG, were also prepared as follows: 20 mM
of the corresponding porphyrin in DMSO (1 mL) were added to
a vial containing 450 mg of dry NR. Before starting the incuba-
tion, and at 2–3 hours intervals, the vials were sonicated to
favour the homogeneity of the suspensions of the NR. The
samples were le in incubation for 48 hours, aer which the NR
were washed (5  1 mL) with DMSO, by suspending with
ultrasounds and then by removing the solvent using a magnet
to trap the NR. The NR were then washed once with 1 mL of
ethanol and dried.
The functionalization of the NR was corroborated by means
of three experimental techniques: uorescence microscopy,
TGA and electrochemical probe experiments. TGA was carried
out in order to establish the amount of loaded porphyrin, and to
evaluate the thermal stability of the functionalized NR. Cyclic
voltammetries of the Fe(II)/Fe(III) system in a 2mMK4[Fe(CN)6] +
2 mM K3[Fe(CN)6] + KNO3 0.2 M solution (electrochemical
probe) were recorded in order to detect possible variations in
the proles of NR functionalized with porphyrins respect to that
of non-functionalized NR. Before each experiment, 2.5 mL of
suspensions of functionalized and non-functionalized NR in
mixtures of water : ethanol (4 : 1) were dropped on the surface
of a glassy carbon rod (electrodes of 0.0314 cm2) and then were
dried under a nitrogen ow.
Functionalization of microparticles (mP)
The microparticles (mP) used in this study were prepared as
described elsewhere;48 and consist of a layer of polysilicon and
a layer of gold attached by a thin chromium layer. Three
diﬀerent samples were prepared: a control sample containing16966 | RSC Adv., 2017, 7, 16963–16976MTMS and MHEG (PEG-mP), a sample with MTMS and ATPP-LA
(ATPP-LA-mP), and a sample with MTMS and ZnATPP-LA
(ZnATPP-LA-mP). The functionalization was performed as
follows: 100 mL of piranha solution were added to a microtube,
containing approximately 106 microparticles, and the micro-
particles were incubated for 1 hour at room temperature with
continuous shaking at 400 rpm. The suspensions were then
centrifuged for 15 minutes at 13 500 rpm, washed twice with
MilliQ water (1 mL) and once with DMSO (1 mL). For control
microparticles PEG-mP, 100 mL of a MHEG solution in DMSO (6
mM) were added. For microparticles with the porphyrins ATPP-
LA-mP and ZnATPP-LA-mP 100 mL of solutions of the porphyrins
ATPP-LA or ZnATPP-LA in DMSO (1.2 mM) were added,
respectively. The suspensions of microparticles with MHEG or
with porphyrins were le for 48 hours at room temperature in
a shaker at 400 rpm. Then they were centrifuged for 15 minutes
at 13 500 rpm. The supernatant was recovered for porphyrin
determination and the mP were washed twice with DMSO (1
mL). Then, the surface containing polysilicon was functional-
ized by incubating with 100 mL of 10% MTMS in DMSO for 2
hours at room temperature, aer which they were centrifuged
for 15minutes at 1350 rpm and washed twice with DMSO (1mL)
and twice with ethanol (1 mL) and air dried and then suspended
in 10 mL of culture medium (DMEM) to calculate the nal
concentration of mP using a Neubauer Chamber and counting
the particles with an optical microscope.
Singlet oxygen production of the ATPP-LA1, ATPP-LA, ZnATPP-
LA, ATPP-LA-GNP and ZnATPP-LA-GNP
Singlet oxygen formation can be monitored indirectly through
the conversion of ABMA into an endoperoxide which can be
detected by uorescence spectroscopy. Briey, 3 mL of a solution
5.12  104 M of ABMA in MeOH were added to the cuvettes
containing (3.93 mL, 3.84 mL or 4.07 mL) of ATPP-LA1, ATPP-LA or
ZnATPP-LA solutions in DMSO respectively, to give a nal
concentration of porphyrin in the cuvette of 3 mM. In the case of
the GNP, 3 mL of ABMA (5.12  104 M in MeOH) were added to
cuvettes containing (512 mL or 384 mL) of aqueous solutions of
ATPP-LA-GNP or ZnATPP-LA-GNP respectively, to give the same
concentration of ATPP-LA or ZnATTP-LA (3 mM). The solutions
were added to a quartz cuvette and stirred thoroughly. A light
source with a range between 400 nm and 500 nm was used to
irradiate the stirred solutions during 4 hours. Fluorescence
spectra were recorded every hour, in the range of 390–600 nm,
and the singlet oxygen production was determined by the
decrease of the uorescence intensity of ABMA.
Cytotoxicity and photocytotoxicity studies
HeLa cells (human cervical adenocarcinoma cells; ATCC CCL-2)
were used to test the cytotoxicity and the photocytototoxicity of
the diﬀerent porphyrins (TPPNH2 and ZnTPPNH2) and the
controls of the carriers (GNP, NR and mP) and loaded with the
porphyrins (ATPP-LA-GNP, ZnATPP-LA-GNP, ATPP-LA-NR,
ZnATPP-LA-NR, ATPP-LA-mP and ZnATPP-LA-mP). HeLa cells
were cultured at 37 C in a humidied sterile atmosphere of
95% air and 5% CO2, using DMEM supplemented with FBSThis journal is © The Royal Society of Chemistry 2017
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View Article Online(10% v/v), glucose (4.5 g L1), L-glutamine (292 mg L1), strep-
tomycin sulphate (50 mg L1) and potassium penicillin (50 000
U L1). For cytotoxicity studies, cells were seeded in 96-well
plates (3300 cells per well) and grown up to 70–85% conuence.
Cells were then incubated for 24 hours with diﬀerent concen-
trations of the porphyrins in solution (0–100 mM), each vehicle
control: (0–150 mg mL1 of NR; 0–100 nM of GNP); 0–400 000 mP
mL1) or each vehicle loaded with either porphyrin (0–20.8 mg
mL1 of NR; 0–100 nM of GNP; 0–400 000 mP mL1). Cells
incubated with the complete medium in the absence of vehicles
were used as control. Aer incubation, the medium was dis-
carded, cells were washed three times with cold PBS and incu-
bation was followed for 24 additional hours with fresh culture
medium. Cell viability was determined by means of the MTT
assay. Briey, the remaining HeLa cells were incubated with
a MTT solution (0.05 mg mL1) in complete DMEM for 3 hours.
The medium was discarded, formazan crystals were solubilized
with pure DMSO and the formazan concentration was deter-
mined by absorption at 526 nm. Cell viability was determined by
the ratio between the absorbance of treated cells and that of
non-treated cells (control, 100% viability).
For photocytotoxicity studies, cells were incubated with
porphyrins or with the porphyrin-loaded vehicles for 24 h,
washed three times with cold PBS and feed with fresh complete
medium and then were irradiated using a LED source (LED par
64 Short, ShowTec) of a wavelength range of 515  50 nm, with
a light intensity at the irradiation site of 6 mW cm2. Samples
were irradiated at diﬀerent times ranging from 2 min to 32 min
to achieve the intended light uence. Cells were again incu-
bated for 24 h in the dark and the reduction in cell viability was
also determined by means of the MTT assay.Fig. 1 Structure of the porphyrins ATPP-LA and ZnATPP-LA.Internalization study of the diﬀerent vehicles
Confocal microscopy was used to verify ZnATPP-LA-GNP,
ZnATPP-LA-NR and ZnATPP-LA-mP internalization. Cells were
grown in an 8 wells Chamber Coverglass Nunc Lab-Tek II. First,
cells were incubated at 37 C for 24 h with a suspension of the
corresponding ZnATPP-LA-loaded carrier in DMEM (15 nM
ZnATPP-LA-GNP, 15.6 mg mL1 ZnATPP-LA-NR and 60 000
ZnATPP-LA-mP ml1) to allow their internalization. The
concentrations used for each vehicle were chosen in order to
have the maximum amount of the vehicle in solution that
allows a HeLa cell viability (in the dark) above 80%. To conrm
the intracellular localization of the carriers, the cytoplasm of the
cells was labelled with the CellTracker™ uorescent probe
Green CMFDA (5-chloromethyluorescein diacetate) in serum-
free culture medium, which acts as a cytoplasm cell tracker
(C7025 Thermo Fisher, Life Technologies). The methodology of
the labelling process consists in the following steps: (1) cells
were washed twice for 5 min with PBS (1 mL), (2) incubated for
30 min at 37 C with the binding solution (5 mM CMFDA in
serum-free culture medium) (2 mL), (3) washed twice for 5 min
with PBS (1 mL), (4) incubated for 30 additional min at 37 C
with supplemented cell culture medium; and (5) lastly washed
twice for 5 min with PBS (1 mL). Aer labelling, the cells were
maintained in complete culture medium containing 10 mMThis journal is © The Royal Society of Chemistry 2017HEPES to keep cells alive during its observation with the
microscope. HeLa cells were imaged using a Leica TCS SP2
confocal laser uorescence microscope (Leica, Heidelberg,
Germany) with simultaneously uorescence and reection
acquisition, to detect the cell marker and the vehicles respec-
tively, by using an argon laser of 488 nm. Diﬀerent sections were
initially scanned, and a data set of z-series images were
collected from the bottom of the wells toward the top in the z-
axis direction. Three-dimensional reconstructions were made
with the soware Imaris 7.2.3 (Bitplane AG, USA).Results and discussion
Synthesis and characterization of porphyrin-functionalized
GNP, NR and mP
In this work, the main objective was to incorporate two
porphyrins, one of them containing a metal in its core, in
diﬀerent nanostructured materials with a gold shell in order to
understand the inuence that size, morphology and composi-
tion has in their bio-photoactivity, and therefore select the best
carriers to be used as delivery vehicles for PDT. In order to do so,
we used a multidisciplinary approach combining synthesis of
nanomaterials, microfabrication, surface chemical functional-
ization and cell biology studies (cytotoxicity and photo-
cytotoxicity, cellular internalization), to prepare hybrid
nanostructured materials capable to interact with living cells,
and deliver photoactive drugs. Prior to the materials function-
alization, porphyrin derivatives adequate to immobilization in
the potential vehicles had to be synthetized. The characteriza-
tion of the disulphide-bearing amidoporphyrins ATPP-LA and
ZnATPP-LA (Fig. 1) and the synthesis and characterization of
their precursors50–53 can be found in Section 1 in ESI (detailed
synthetic procedure and characterization, Schemes S1, S2 and
Fig. S1–S16).† LA was chosen in this work to act as linker for the
correct immobilization of the porphyrins (ATPP-LA and
ZnATPP-LA) in the vehicles, because this compound is
commonly used for electrochemical studies of biomolecules or
for the elaboration of biological sensors54,55 and coupled to
a porphyrin.56
Due to instability of the porphyrin ATPP-LA which results in
its oxidation, ATPP-LA was used in situ in the functionalization
of the three diﬀerent vehicles.RSC Adv., 2017, 7, 16963–16976 | 16967
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View Article OnlineThe synthesized porphyrins ATPP-LA and ZnATPP-LA were
conjugated to three diﬀerent vehicles, each with diﬀerent
characteristics given by their corresponding materials and
dimensions, that can help improve their therapeutic eﬀect.
Therefore, we chose to study:
(1) GNP, widely studied as vehicles for diﬀerent types of
therapy, can easily enter the cells due to their small size, and
due to a high area/volume ratio allow a high loading of
porphyrin molecules on their surface;45,57,58
(2) biocompatible CoNi NR covered with a gold layer,46 that
confers inertness to the system and allows a facile functionali-
zation, while the CoNi core renders them magnetic, making
possible to direct the vehicle by applying a magnetic eld, thus
avoiding side eﬀects caused by non-specic distribution of the
PS in the organism; and
(3) biocompatible Janus mP with two diﬀerent materials (gold
and polysilicon) with dimensions in the micrometric scale.
These mP can be internalized by cells,49 and the presence of two
surfaces from diﬀerent materials can be used to functionalize
each of the surfaces with diﬀerent molecules,48 such as the PS in
one face and a targeting molecule or a hydrophilic molecule
such as polyethyleneglycol (PEG) on the other face.
From these materials, the gold nanoparticles are synthesized
in situ in the presence of the porphyrins while the microparti-
cles and the nanorods are fabricated prior to the immobiliza-
tion of the porphyrins, through processes already described.
The magnetic CoNi core of the NR is electrochemically grown in
a polycarbonate membrane, which is later dissolved, and the
released NR are then covered with a gold layer through galvanic
displacement (see ESI Fig. S17† for their preparation).46 The mP
composed of gold and polysilicon surfaces are fabricated
through photolithography: the polysilicon layer is deposited on
top of a sacricial layer, then a chromium layer (to help the
adhesion between the polysilicon and the gold), and nally the
gold layer is deposited (see ESI Fig. S18† for microfabrication
details).48 Fig. 2 shows the SEM images of the NR and the
microparticles, prior to functionalization, depicting their
shape, dimensions and surface composition. Each of these
vehicles has a specic characteristic: the GNP have high area/
volume ratio, the NR have a magnetic CoNi core useful to
direct these carriers to the tumour tissue, and the mP have a gold
surface and a polysilicon surface that can be used to immobilize
diﬀerent molecules.
According to literature, somemetals can aﬀect the formation
of singlet oxygen by porphyrins and, consequently, their
photodynamic eﬀect when these metals are coordinated in theFig. 2 SEM image and schematic representation of (a) nanorods and
(b) microparticles, with their corresponding dimensions and surface
composition.
16968 | RSC Adv., 2017, 7, 16963–16976core of the porphyrin ring. In this study we use the same
porphyrin with and without Zn in their core. Apart from the Zn,
the only metal found in the proximity of the porphyrin is gold
but it is not part of the porphyrin molecule and the linkage of
the porphyrin with the gold shell is the same for all the vehicles.
Co and Ni are in the core of the nanorods, and therefore they are
not in contact with the porphyrin, and Cr is present as a thin
layer between gold and polysilicon in the microparticles, as
a “cement” to attach the two materials, and is not in contact
with the porphyrin because the molecules are immobilized on
the gold surface.
For each vehicle (GNP, NR or mP), due to their diﬀerences in
material composition, size, morphology and preparation
method, diﬀerent methodologies were used for the functional-
ization with the porphyrins ATPP-LA and ZnATPP-LA, and
consequently the distribution of the molecules on the surface is
expected to be diﬀerent. Fig. 3 shows the schematic represen-
tation of each nanostructure containing the porphyrins, as well
as a PEG-derivative used to increase the water dispersability of
the hybrid nanomaterials.Fig. 3 Schematic representation (cross-section) of GNP: ATPP-LA-
GNP (M ¼ H,H) and ZnATPP-LA-GNP (M¼ Zn), NR: ATPP-LA-NR (M ¼
H,H) and ZnATPP-LA-NR (M¼ Zn), and mP: ATPP-LA-mP (M¼H,H) and
ZnATPP-LA-mP (M ¼ Zn).
This journal is © The Royal Society of Chemistry 2017
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View Article OnlineIn the case of the GNP, the synthesis was adapted from the
Brust–Schiﬀrin biphasic method59 and was performed in the
presence of the disulphide-bearing amidoporphyrin derivatives
ATPP-LA or ZnATPP-LA, so that the nal GNP already incorpo-
rated these porphyrins in their structure. To make the GNP
more hydrophilic and biocompatible, 11-mercaptoundecyl)
hexa(ethylene) glycol (MHEG) was also introduced. The initial
molar ratio between the MHEG and the porphyrin used was
2 : 1. The S–S bond is sensitive to the presence of reducing
agents such as NaBH4 (used for GNP synthesis).60 For this
reason, to avoid a competition between the reduction of the
gold salt and LA, we decided to use an excess of NaBH4 in the
synthesis of GNP to ensure the reduction of the gold salt. LA is
consequently also reduced by NaBH4 to dihydrolipoic acid
(DHLA), which have also been proven to be a valuable ligand for
stabilizing and inhibiting the aggregation of GNP.61,62
The newly synthesized GNP were characterized by Trans-
mission Electron Microscopy (TEM) and Dynamic Light Scat-
tering (DLS) in the preparation medium, in order to determine
their size, morphology and size distribution. Fig. 4 shows the
TEM micrographs obtained for both synthesized ATPP-LA-GNP
and ZnATPP-LA-GNP, and their respective distribution histo-
grams. In both cases, the obtained GNP, loaded with the amido-
disulde porphyrin derivative and the PEG-derivative MHEG,
presented spherical shape and are monodisperse, with narrow
size distribution. The GNP gold core has an average diameter of
9.5 1.5 nm and 10 1.3 nm for ATPP-LA-GNP and ZnATPP-LA-
GNP respectively, as measured by TEM, and hydrodynamic
diameter of 13.0  0.8 nm and 13.5  1.0 nm for ATPP-LA-GNP
and ZnATPP-LA-GNP respectively, as measured by DLS, which
takes into account the organic shell composed by the thiol
ligands used to stabilize the GNP. DLS analysis also showed that
these GNP are stable in solution and present low polydispersity
index between 0.11–0.13. Furthermore, when the carriers were
added to the culture medium no turbidities appear that could
indicate the formation of aggregates.63
Fluorescence spectroscopy was used to conrm the presence
of the two synthesized porphyrins ATPP-LA and ZnATPP-LA onFig. 4 TEM micrographs of (a) ATPP-LA-GNP and (b) ZnATPP-LA-
GNP and (c and d) size distribution histograms of both GNP
respectively.
This journal is © The Royal Society of Chemistry 2017the GNP surface thanks to the ability of the porphyrins to emit
uorescence.64 The uorescence emission spectra were recor-
ded for the free porphyrins (ATPP-LA and ZnATPP-LA) in CHCl3
solution and for the porphyrin-coated GNP in aqueous solution
(see ESI Fig. S19 and S20†). The uorescence emission spectra
of the metal-free porphyrin ATPP-LA and of the ATPP-LA-GNP
exhibit two peaks at ca. l 652 and 709 nm (excitation at 590 nm)
as it was expected for the non-metallated porphyrin derivatives
(see ESI Fig. S20†),64 while in the case of the metallated
porphyrin ZnATPP-LA and ZnATPP-LA-GNP the uorescence
emission spectra of both samples exhibit two peaks at ca. l 600
and 650 nm (excitation at 550 nm) as expected for Zn-porphyrin
derivatives (see ESI Fig. S20†).65 These results indicate the
immobilization of both porphyrins (ATPP-LA and ZnATPP-LA)
into GNP, and also demonstrate that the uorescence emission
of the photosensitizer is not aﬀected signicantly when the
porphyrin is linked to the GNP.
Through UV-visible absorption spectroscopy it was possible
to conrm the presence of the porphyrins in the synthesized
GNP (see ESI Fig. S21†) and quantify the total amount of
immobilized porphyrin in the GNP using the porphyrins'
characteristic Soret band and the Q bands present in the
absorption spectra. To calculate the extinction coeﬃcient of the
porphyrins, a calibration curve was obtained in the range 0.5–10
mM for both ATPP-LA and ZnATPP-LA (see ESI, Fig. S22 and
S23†). GNP concentration was determined applying calculations
described by Haiss,66 and the amount of porphyrins per GNP
was then calculated. The ratio of incorporated porphyrin per
nanoparticle was found to be 1.67  104 ATPP-LAmolecules per
GNP and 2.81  103 ZnATPP-LA molecules per GNP (see ESI
Table S1† for details).
In the case of the NR, an initial ratio of 10 : 1 MHEG/
porphyrin was used (see Fig. 5a): the porphyrin used is hydro-
phobic and the material also has low water dispersability.
Therefore, we used a higher ratio of MHEG than the one used
for the GNP, to increase the dispersability in water of the
porphyrin-loaded NR, but still maintaining a high porphyrin
content. The successful immobilization of the porphyrins on
their gold surface was assessed by uorescence microscopy,
since porphyrin-functionalized NR should present red coloured
uorescence. Fig. 5b and c show images of naked NR, and
Fig. 5d and e of the porphyrin-functionalized NR ATPP-LA-NR
and ZnATPP-LA-NR respectively, with visible red coloured
uorescence of the porphyrin, conrming its presence linked to
the NR surface. The NR, being magnetic, have a natural
tendency to aggregate, fact that was favoured due to the
necessity of drying the sample for observation in the micro-
scope. Furthermore, NR functionalization was conrmed using
electrochemical characterization. Control NR containing the
porphyrin ATPP-LA or ZnATPP-LA, but no PEG-derivative
(MHEG), were also prepared, and identied as NR-H and NR-
Zn, respectively. The functionalization was corroborated by
comparing the electrochemical probe of Fe(II)/Fe(III) redox
couple response of non-functionalized (NR) and functionalized
(ATPP-LA-NR, ZnATPP-LA-NR, PEG-NR, NR-H and NR-Zn) NR.
The results are shown in Fig. 5f.RSC Adv., 2017, 7, 16963–16976 | 16969
Fig. 5 Schematic representation of the NR functionalization with
either ATTP-LA or ZnATPP-LA (a); ﬂuorescence microscope images
showing a mesh of non-functionalized naked NR (b) and the corre-
sponding image with visible light (c); ﬂuorescence microscope images
showing a mesh of porphyrin-functionalized ATPP-LA-NR (d) and
ZnATPP-LA-NR (e), identiﬁed by the red color. Magniﬁcation 400;
Electrochemical probe of Fe(II)/Fe(III) system at 100 mV s1 (f) showing
curves for non-functionalized naked NR (A), NR-H (B), NR-Zn (C),
ATPP-LA-NR (D), ZnATPP-LA-NR (E) and PEG-NR (F).
Fig. 6 Schematic representation of the mP functionalization with
either ATTP-LA or ZnATPP-LA (a); ﬂuorescence microscope images of
bifunctional microparticles functionalized with ATPP-LA (b) and
functionalized with ZnATPP-LA (c).
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View Article OnlineAs expected, the formation of an organic layer on the NR
surface creates an additional barrier on the electrode, which
results in a decrease in peak mass-normalized current density
(jp), while peak-to-peak separation (DEp) increases. Thus, there
is a signicant decrease in peak mass-normalized current
density and increase in the separation of the peaks when NR
were functionalized with porphyrins ATPP-LA and ZnATPP-LA
and without MHEG (NR-H and NR-Zn, respectively) (curves B
and C respect to curve A), with a blocking eﬀect slightly higher
in the case of NR-Zn. Therefore, the electrochemical tests clearly
show that NR could be easily functionalized with both porphy-
rins and PEG-derivative.
Because NR scatter light when in suspension, it was not
possible to quantify the amount of porphyrin by measuring the16970 | RSC Adv., 2017, 7, 16963–16976UV-visible absorption spectra of the samples. Measuring the
amount of porphyrin remaining in the supernatant did not
provide good results either. Therefore, the amount of loaded
porphyrin per mass of NR and the thermal stabilities of the non-
functionalized and functionalized samples were evaluated by
thermogravimetric analysis (see ESI Fig. S24†). The amounts
found per mg of NR were 0.011 mmol of ATPP-LA in ATPP-LA-NR
and 0.016 mmol of ZnATPP-LA in ZnATPP-LA-NR.
For the immobilization of the porphyrins in the mP, because
these particles have two surfaces, each of a diﬀerent material,
they must be functionalized in a sequential manner as
described elsewhere48 (see Fig. 6a).
First, the gold surface was functionalized with the porphyrin
(ATPP-LA or ZnATPP-LA) and then the polysilicon surface was
functionalized with a silane derivative containing poly-
ethyleneglycol groups, namely (6-{2-[2-(2-methoxyethoxy)
ethoxy]ethoxy}hexyl)trimethoxysilane (MTMS), to improve the
water solubility and biocompatibility (see ESI, Scheme S3†). The
presence of the porphyrins on the microparticles, indicating
their successful immobilization, was assessed by uorescence
microscopy. The functionalized microparticles show a red
bright uorescence observed due to the presence of the
porphyrins. Furthermore, they show homogeneous uores-
cence intensity and no signicant diﬀerences were observed
between the immobilized microparticles with porphyrins ATPP-
LA or ZnATPP-LA (Fig. 6b and c, respectively). The amount of
porphyrin immobilized in the functionalized microparticles
was determined indirectly using UV-visible absorption spec-
troscopy, by calculating the diﬀerence between the initial
amount of porphyrin in solution and the nal amount present
aer incubation with the vehicles, using the calibration curvesThis journal is © The Royal Society of Chemistry 2017
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View Article Onlinewith a range of 0.50–10 mM of ATPP-LA or ZnATPP-LA (see ESI,
Fig. S22 and S23, respectively†). It was found that the samples of
ATPP-LA-mP contained 1.8 mM ATPP-LA and the samples of
ZnATPP-LA-mP contained 1.4 mM ZnATPP-LA. These concentra-
tions correspond to suspensions of 500 000 mPs mL1.
The geometric area for each vehicle was estimated from their
dimensions, being 3.1  104 mm2 (GNP), 1.30 mm2 (NR) and 9
mm2 (mP). In the case of the bifunctional Si/Au mP, only the gold
layer has been considered for the porphyrin adsorption. With
these values, the content of porphyrin per mm2 could be calcu-
lated. In order to compare the amount of porphyrins incorpo-
rated in the diﬀerent vehicles, the micromoles of porphyrin
loaded in each vehicle was determined. A brief summary of the
characteristics of all the vehicles, including their materials,
shape, dimensions, and content in porphyrin per vehicle and
per area, is presented in Table 1.
Due to the diﬀerent size and shape of each carrier, the
amount of PS molecules attached to the carrier was expected to
be diﬀerent. All the carriers retain porphyrin in the surface as
a consequence of the bonds between the molecules and the
supercial gold. The porphyrin/vehicle unit ratio increases in
the sense GNP < NR < mP, due to the clear diﬀerences in the size
of each vehicle. However, the amount of immobilized porphy-
rins is not directly proportional to the geometrical gold surface.
When comparing the amount of linked porphyrin ATPP-LA by
gold surface unit, we found a higher porphyrin/gold surface
ratio for the mP (5.1  1010 mmol mm2) than for GNP (9.0 
1011 mmol mm2) or NR (2.6  1012 mmol mm2).
The same trend was observed for the vehicles loaded with
ZnATPP-LA, where again the highest porphyrin/gold surface
ratio was obtained for the mP (4.0  1010 mmol mm2), then for
GNP (15.0  1011 mmol mm2) and the lowest for the NR (2.6 
1012 mmol mm2). The NR present the lower porphyrin/gold
surface ratio for both porphyrins, probably as a consequence
of partial NR aggregation during the functionalization process.
Although ultrasound conditions were used during functionali-
zation, the relatively short PEG-derivative leads to low screening
of the magnetic elds induced by the NR, and therefore not
being able to prevent the formation of some aggregates that
hinder the porphyrin adsorption over some parts of the NR
surface.
Instead, the highest content for both porphyrins was found
in the mP, which can be justied by their bifunctional nature:
the PEG-derivative used to make the particles more water-Table 1 Characterization of the three vehicles loadedwith the porphyrins
their shape, dimensions, and content of porphyrin per vehicle unit
Material Shape and dimensions
Gold nanoparticle Sphere Ø ¼ 9–10 nm
Nanorod with gold shell and Co/Ni core Cylinder Ø ¼ 110 nm, 3.7 mm
Gold and polysilicon microparticle Cuboid 3 mm  3 mm  530
This journal is © The Royal Society of Chemistry 2017soluble and biocompatible was immobilized on the silicon
face of the microparticles, whereas all the gold face remains free
for the porphyrin chemisorption. Additionally, the gold layer is
a rougher surface in the mP, also contributing to a higher
incorporation of porphyrin. For the other two types of vehicles,
both porphyrin and PEG-derivative compete by the gold surface,
forming a mixed SAM with both polyethyleneglycol and
porphyrin molecules, and therefore the amount of porphyrins
by gold area is lower.Singlet oxygen production quantication
Singlet oxygen production was examined using the probe
ABMA. In the presence of singlet oxygen, ABMA is converted
into an endoperoxide, leading to a decrease in the uorescence
emission of the molecule due to photobleaching.67 The emis-
sion decay can be easily followed using uorescence spectros-
copy. To study de singlet oxygen production, the
photosensitizer was irradiated in the presence of ABMA with
a blue light source. It was veried that aer 1 hour the decay of
the uorescence of the ABMA was low, and therefore the irra-
diation time was increased to 4 hours with continuous stirring,
to obtain a cumulative eﬀect where the diﬀerence between the
diﬀerent decay rates could be more noticeable. Fluorescence
emission spectra were recorded every hour, in the range of 390–
600 nm, and the singlet oxygen production was determined by
the decrease of the emission intensity of the ABMA (see ESI,
Fig. S25†). A considerable decay of the ABMA uorescence
emission band during irradiation was observed, demonstrating
the formation of the endoperoxide from the ABMA due to
singlet oxygen production in all samples. A control sample
containing ABMA solution without any porphyrin, irradiated
under the same conditions, shows a negligible decay in the
ABMA uorescence emission. This result conrms that singlet
oxygen was produced by the porphyrin derivatives, alone or
loaded in the GNP, upon irradiation. It can be observed that
aer 4 hours the percentage of emission decay for ABMA in the
presence of ATPP-LA1, ATPP-LA, and ZnATPP-LA was 19%, 17%
and 37% respectively, and for ATPP-LA-GNP and ZnATPP-LA-
GNP were 42% and 60%, respectively, indicating the production
of singlet oxygen in all cases (see Fig. S26 in ESI†). It is also
evident the diﬀerences in the ABMA uorescence decay between
the samples containing the porphyrins withoutmetal (ATPP-LA1
and ATPP-LA) and those with the porphyrin containing zinc in: the table shows thematerials used in the procurement of the vehicles,
Vehicle
Porphyrin/vehicle
(mmol/unit)
Porphyrin/area
(mmol mm2)
ATPP-LA-GNP 2.8  1014 9.0  1011
ZnATPP-LA-GNP 4.7  1014 15.0  1011
length ATPP-LA-NR 3.4  1012 2.6  1012
ZnATPP-LA-NR 5.0  1012 3.8  1012
nm ATPP-LA-mP 4.6  109 5.1  1010
ZnATPP-LA-mP 3.6  109 4.0  1010
RSC Adv., 2017, 7, 16963–16976 | 16971
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View Article Onlinetheir core. This diﬀerence is associated to the presence of the
zinc metal in the porphyrin molecule, which increases the
capacity of the photosensitizer to generate singlet oxygen, as
reported in the literature,12,68,69 making this metalloporphyrin
a promising PS for PDT. Finally, in order to compare the singlet
oxygen production capacity of the free porphyrins (ATPP-LA1,
ATPP-LA and ZnATPP-LA) and of the porphyrins loaded in the
GNP (ATPP-LA-GNP and ZnATPP-LA-GNP), the maximum rate of
ABMA photobleaching was normalized with the concentration
of the PS using eqn (1), where IF is the intensity of uorescence.
ð%IF431 at t ¼ 0 minÞ  ð%IF431 at t ¼ 60 minÞ
60 min ½porphyrinðmMÞ (1)
The concentration of porphyrin in the solution was 3 mM,
whether it was free in solution (ATPP-LA and ZnATPP-LA) or
loaded in the GNP (ATPP-LA-GNP and ZnATPP-LA-GNP). All of
the calculated maximum rates of ABMA photobleaching upon
irradiation are compared in Fig. 7. The highest values of
maximum rate of ABMA photobleaching, directly related to the
singlet oxygen production, were obtained for both GNP (0.055%
and 0.066% uorescence emission decay per min per mM for
ATPP-LA-GNP and ZnATPP-LA-GNP, respectively). ATPP-LA1 and
ATPP-LA showed the lowest values (0.027% and 0.033% uo-
rescence emission decay per min per mM respectively), while
ZnATPP-LA shows a value of 0.050% uorescence emission
decay per min per mM, which is lower than that obtained for
ZnATPP-LA-GNP. It is noteworthy that the zinc-containing
porphyrin ZnATPP-LA presents a maximum rate of ABMA pho-
tobleaching higher than the porphyrin without metal ATPP-LA
when it was used alone or loaded in GNPs. This is in agreement
with the fact that the zinc-containing porphyrin has a better
capacity to produce singlet oxygen than the porphyrin without
metal.
Moreover, when comparing the porphyrins ATPP-LA and
ZnATPP-LA free in solution and loaded in the GNP, the increase
observed in the rate of ABMA photobleaching is visible. These
results demonstrate that the porphyrins resulted more eﬀective
when immobilized on GNP rather than free in solution, with an
increased singlet oxygen production, a feature already observedFig. 7 Percentage rate of the photobleaching of ABMA at 431 nm,
normalized to porphyrin concentration.
16972 | RSC Adv., 2017, 7, 16963–16976before for similar systems,15,27,70 which may be attributed to the
high localized plasmonic eld generated in the gold surface
that enhances ROS production.27 This fact is even more
remarkable considering that the photobleaching of the
porphyrin-loaded GNP has been measured in aqueous solution,
where oxygen is much less soluble and usually leads to a less
signicant eﬀect for this type of measurement because of the
shorter lifetime of singlet oxygen in water.71Cytotoxicity and photocytotoxicity studies
Regarding the toxicity of the vehicles, previous studies with the
NR functionalized with thiolated PEG allowed determining
their biocompatibility.46 To assure that the GNP and the mP did
not have intrinsic toxicity to the used cell lines, a viability study
was also performed, both vehicles being coated with PEG-
containing thiol and no porphyrin. It was found that the
viability of the cells was higher than 80% for the maximum
concentrations tested of 100 nM and 410 000 mP mL1,
respectively (see ESI Fig. S27 and S28†). This suggests that the
thiol group which interacts with the gold surface does not exert
a toxic eﬀect on the cells. The cytotoxicity of porphyrins, both in
solution and aer immobilization in the diﬀerent vehicles, was
determined using HeLa cells. Porphyrins TPPNH2 and
ZnTPPNH2 were used as controls in solution, rather than ATPP-
LA or ZnATPP-LA, because of their higher solubility in polar
solvents. In this study, the manipulation of the cells was per-
formed in the dark, so the results reect the cytotoxicity in the
absence of light irradiation and thus without singlet oxygen in
the incubates. The purpose of this study was to nd the
adequate concentrations of porphyrins, free in solution and
loaded in the diﬀerent vehicles, at which HeLa cells viability was
higher than 80–90% in the dark. The results obtained are shown
in ESI Fig. S29–S32.† With these data, the maximum concen-
tration of porphyrins, free or loaded in the carriers, were chosen
to be used in the photocytotoxicity assays. Cytotoxicity follows
a general trend, as the Zn containing porphyrins were more
toxic than their non-metallated analogues, both in solution and
aer immobilization into the diﬀerent vehicles. To study the
photocytotoxicity, diﬀerent porphyrin concentrations and light
doses were used. The study was performed with HeLa cells and
cell viability was determined for the free porphyrins TPPNH2
and ZnTPPNH2 (Fig. 8a and b) and for the porphyrins loaded in
the three diﬀerent vehicles: GNP (Fig. 9a and b), NR (Fig. 9c and
d) and mP (Fig. 9e and f). The results obtained for the viability of
HeLa cells in the presence of free porphyrins showed that in the
dark (light dose ¼ 0) the survival cell fraction was higher than
95% for porphyrin concentrations up to 1 mM and demonstrated
that the incubation of HeLa cells with both porphyrins at the
concentrations used did not induce signicant cell death
without irradiation.
More importantly, the results showed the concentration and
light dose dependence of the photodynamic response of HeLa
cells for both porphyrins (TPPNH2 and ZnTPPNH2). As ex-
pected, increasing the concentration of porphyrin and light
dose causes an increase of photocytotoxicity. At the same
porphyrin concentration and light dose, the photocytotoxicThis journal is © The Royal Society of Chemistry 2017
Fig. 8 HeLa cells viability (expressed in percentage with respect to
controls) after irradiation at diﬀerent light doses in the presence of: (a)
TPPNH2 and (b) ZnTPPNH2. The concentration of porphyrin in each
incubate is the indicated in the ﬁgure. Control cells were incubated
only with complete growth medium. The results displayed are the
average values obtained by three independent experiments (n¼ 3) and
the error bars correspond to standard deviation.
Fig. 9 HeLa cells viability (expressed in percentage with respect to
controls) after irradiation at diﬀerent light doses in the presence of: (a)
ATPP-LA-GNP and (b) ZnATPP-LA-GNP; (c) ATPP-LA-NR and (d)
ZnATPP-LA-NR; and (e) ATPP-LA-mP and (f) ZnATPP-LA-mP. The
concentration of porphyrin in each incubate is the indicated in the
ﬁgure. Control cells were incubated only with complete growth
medium. The results displayed are the average values obtained by
three independent experiments (n ¼ 3) and the error bars correspond
to standard deviation.
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View Article Onlineeﬀect was more pronounced in the case of the metallated
porphyrin (ZnATPP-LA), as expected by the increased produc-
tion of singlet oxygen by this porphyrin, demonstrated by the
increased ABMA photobleaching decay (Fig. 7). This result is in
agreement with the production of singlet oxygen by related
photosensitizers such as tetraphenylporphyrin and Zn(II)-tetra-
phenylporphyrin assessed by means of time-resolved near-
infrared phosphorescence detection.72 Using the non-cytotoxic
highest porphyrin concentration (1 mM) and light dose 15 JThis journal is © The Royal Society of Chemistry 2017cm2, the viability of HeLa cells was around 25% for ZnTPPNH2
which contrasts greatly with HeLa cells viability near 60% found
for TPPNH2, conrming the higher eﬃciency of ZnTPPNH2, in
accordance with the results obtained for other similar
systems.12,68
Similar experiments were performed to demonstrate the
usefulness of the synthesized porphyrin-loaded vehicles (with
porphyrins bound to their gold surface) as eﬃcient porphyrin
carriers for PDT. It was observed that the global behaviour of
HeLa cells incubated with both porphyrins loaded in the
diﬀerent vehicles is similar to that obtained for the free
porphyrins. Also, HeLa cells viability decreases by increasing
the porphyrin concentration in the incubation medium and the
light dose used in the irradiation process. Moreover, for all
vehicles, the eﬀectiveness was higher when the porphyrin
loaded was ZnATPP-LA. However, to analyze the results together
and highlight the diﬀerences between the diﬀerent vehicles it
must be taken into account that while the light doses used were
the same, the porphyrin concentration in the incubation
medium varies according to their nature (TPPNH2, ZnTPPNH2,
or immobilized in the vehicles as ATPP-LA or ZnATPP-LA) and
according to the vehicle used (GNP, NR or mP). This diﬀerence is
because: rstly, the number of ATPP-LA or ZnATPP-LA mole-
cules in each vehicle varies (see Table 1) and, moreover, the
inherent toxicity of the diﬀerent vehicles determines its
maximum concentration in the incubation medium in order to
obtain a dark cytotoxicity (light dose¼ 0) lower than 20% (% cell
viability$80%). For this, it is necessary to compare the% of cell
viability obtained at the same light dose and with a similar
concentration of porphyrin.
The analysis of the results obtained for the photocytotoxicity
of the porphyrins loaded in the GNP showed that the diﬀerence
between the eﬀectiveness of both porphyrins is even more
evident. Thus, for both porphyrins at the maximum light dose,
the cell viability using the ATPP-LA-GNP ([ATPP-LA] ¼ 1.646 mM)
was of 62% in relation to the control, whereas the use of
ZnATPP-LA-GNP ([ZnATPP-LA] ¼ 0.835 mM) caused a decrease in
cell viability up to 11%, even though the concentration of
ZnATPP-LA was half of the ATPP-LA. Nevertheless, the
enhancement in the photodynamic eﬀect using the ZnATPP-LA-
GNP is greater than the increase in singlet oxygen production
observed using the probe ABMA. It is interesting to note the
increased phototoxicity for ZnATPP-LA observed when the
porphyrin was added to the incubation medium loaded in the
GNP, compared to the photocytotoxicity obtained for the free
porphyrin. A similar concentration of free porphyrin
([ZnTPPNH2] ¼ 1 mM) causes less decrease of cell viability (25%)
than that produced by a concentration of 0.835 mM of the
porphyrin loaded in GNP ZnATPP-LA-GNP (11%). The observed
decrease in cell viability may be a consequence of a more fav-
oured internalization of the porphyrins into HeLa cells when
they were supported on the GNP (see later).
In the case of the NR, the tested amounts of the porphyrins
in the cell viability experiments were greatly limited by the
higher toxicity of the material. Therefore, the concentration of
both porphyrins in the incubation media was lower than that
used for the other vehicles (GNP and mP). In this case, it wasRSC Adv., 2017, 7, 16963–16976 | 16973
Fig. 10 Internalization of ZnATPP-LA-GNP, ZnATPP-LA-NR and
ZnATPP-LA-mP into HeLa cells. HeLa cells were also loaded with the
cytoplasmic Cell Tracker™ Green CMFDA. The cytoplasm is shown in
green (left column), the red images (middle column) correspond to the
porphyrin-loaded carriers and the right column shows their overlay.
The images correspond to sections chosen from a middle plane of the
cells. 3D reconstructions are available as multimedia ﬁles (see ESI†).
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View Article Onlineobserved that for similar porphyrin concentrations ([ATPP-LA]
¼ 0.180 mM; [ZnATPP-LA] ¼ 0.150 mM) and the maximum light
dose, the cell viability using ATPP-LA-NR or ZnATPP-LA-NR was
similar. On the other hand, in both cases the decrease in cell
viability with the increase in porphyrin concentration is less
pronounced than for free porphyrins or loaded in the other two
vehicles. Moreover, at similar porphyrin concentrations and
light dose, the eﬀectiveness in cell toxicity was similar for free
porphyrins and loaded in NR. One possible explanation may be
the diﬃculty of NR to enter the cells causing a reduced avail-
ability of porphyrins as in the other cases (see later). This may
be because of their size and tendency to aggregate, reducing the
uptake of the NR by HeLa cells. To overcome this diﬃculty, the
design of the vehicle may be changed by introducing a PEG-
containing derivative with higher molecular weight, to
improve their dispersion in water and to prevent their
aggregation.
Finally, for the ATPP-LA-mP, the percentage of cell viability
(65%) obtained for a [ATPP-LA] ¼ 1.840 mM, aer the photody-
namic treatment, is comparable with that obtained (62%) for
a similar concentration of the same porphyrin ([ATPP-LA] ¼
1.646 mM) immobilized in the GNP. However when comparing
the photocytotoxic eﬀect of ZnATPP-LA loaded in the mP
(ZnATPP-LA-mP, Fig. 9f) and in the GNP (ZnATPP-LA-GNP,
Fig. 9b), it can be observed that the highest concentration of
ZnATPP-LA (1.440 mM) used for mPs leads to a 28% of cell
viability at the maximum dose of irradiation, while a lower
concentration of the same porphyrin ([ZnATPP-LA] ¼ 0.835 mM)
loaded in the GNP, at the same dose of light, leads to a lower
percentage of cell viability (11%), indicating the higher photo-
toxic eﬃciency of ZnATPP-LA-GNP versus ZnATPP-LA-mP, prob-
ably as a consequence of the higher cellular uptake in the GNP.Internalization study of the ZnATPP-LA-containing vehicles
To enlighten the photocytotoxicity results, the internalization
by HeLa cells of the diﬀerent porphyrin-loaded vehicles was
assessed to determine whether the vehicles enter the cells or
not. Because the amount of porphyrin immobilized per area of
vehicle is diﬀerent in each case, the intensity of the observed
uorescence cannot be directly correlated with the amount of
vehicle entering the cells. Since the higher eﬃciency in the
photodynamic eﬀect was obtained with the zinc-containing
porphyrin, this study was carried out for ZnATPP-LA-GNP,
ZnATPP-LA-NR and ZnATPP-LA-mP. Therefore, HeLa cells were
incubated with these systems for 24 hours, and then labelled
with the cytoplasm marker CMFDA, which shows uorescence
by action of esterases present inside the cell. Fig. 10 shows the
confocal images corresponding to a central plane of HeLa cells,
depicting images corresponding to the green uorescence of
the cell marker, the red images for the vehicles loaded with the
porphyrin, and a merged image of the previous two. 3D recon-
struction of the confocal images is available (see ESI,† multi-
media les 01_GNP_3D, 02_uP_3D and 03_NR_3D).
It can be observed that the amount of ZnATPP-LA-GNP which
is able to enter into HeLa cells is high, and that they are found
inside most of the cells. Thus, despite that ZnATPP-LA-GNP16974 | RSC Adv., 2017, 7, 16963–16976have the least porphyrin load per vehicle unit (7.0  1014 mmol
per GNP), the fact that their uptake by HeLa cells is high helps
to explain why, at the same concentration of porphyrin, its
photocytotoxicity is greater. The images for HeLa cells incu-
bated with ZnATPP-LA-NR shows the presence of some aggre-
gates, which are mainly outside the cells, and this result explain
their low photocytotoxicity; the small amount of ZnATPP-LA-NR
inside the cells determines that the intracellular porphyrin
content is low, and consequently the concentration of singlet
oxygen inside the cells is also small. On the other hand, even
though for NR the area/volume ratio is high, the aggregation of
NR could shield the porphyrin molecules. This fact could
prevent the molecules from generating singlet oxygen during
the irradiation process, and thus would explain the lower pho-
tocytotoxicity found. Thus, it is necessary to improve their
design, as discussed in the previous section, to favour the
capture of NR by HeLa cells, increasing the content of porphyrin
within cells and improving the photocytotoxicity for ZnATPP-
LA-NR. The confocal images of HeLa cells incubated with
ZnATPP-LA-mP indicate a low uptake. The diﬀerent uptake of NR
and mP in relation to that of GNP suggests that the smaller
dimensions of the later (see Table 1) facilitated the uptake by
the HeLa cells, aided by their higher solubility.
Moreover, it must be taken into account the amount of each
porphyrin loaded into each carrier. In this sense, it can be stand
out that mP hold the greater amount of porphyrins while goldThis journal is © The Royal Society of Chemistry 2017
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View Article Onlinenanoparticles contain the least amount. The observed uptake
for mP does not correlate well with the results of their photo-
cytotoxicity. It would be expected that the low amount of mP
inside HeLa cells and the fact that there are few cells containing
mP, would be related to a lower photocytotoxicity as it occurs
when using NR. However, looking at the concentration of
porphyrin ZnATPP-LA that was added to the incubation
medium as ZnATPP-LA-GNP, ZnATPP-LA-NR or ZnATPP-LA-mP,
the results show that at comparable concentrations of
porphyrin, the photocytotoxicity of ZnATPP-LA-mP is interme-
diate between that of the other two formulations, being higher
when using ZnATPP-LA-GNP. This result may be related to the
fact that, in the case of ZnATPP-LA-mP the content of porphyrin
per carrier unit is about 106 times higher than that of the
ZnATPP-LA-GNP and of 103 times higher than that of the
ZnATPP-LA-NR, so that the photocytotoxicity would not depend
only of the amount of the internalized carrier if not mainly of
the total porphyrin content within the cells.
Conclusion
In this work three diﬀerent nanostructured systems have been
used all having a common aspect: a gold surface for easy func-
tionalization with porphyrins containing disulphide groups. The
porphyrins in solution and the porphyrins incorporated in the
vehicles did not show cytotoxicity in the dark but showed good
photocytotoxic eﬀect in HeLa cells when irradiated with light. In
all cases, the zinc-containing porphyrins had higher eﬀect upon
light irradiation. The NR showed the less cytotoxic eﬀect for the
studied concentrations, which were low because of their intrinsic
toxicity and magnetic aggregation, being a possible explanation
for the lower eﬀectiveness observed. To improve the design of the
NR, a thicker hydrophilic layer could be created around them, to
prevent its aggregation and to make them more biocompatible.
mP load the higher amount of porphyrin molecules per carrier
unit, which can explain the considerable cytotoxicity observed
even though the uptake is not so high. Due to their bifunctional
nature, they can be conjugated with internalization agents, such
as transferrin or cell-penetrating peptides, to overcome their low
uptake. GNP had the better photocytotoxicity results, showing
higher eﬀect with regard to that of free porphyrin in solution, as
also observed in the ABMA photobleaching, meaning that the
porphyrin immobilized on the GNP had an enhancement in its
eﬀect. The design of the nanostructures inuenced the amount
of porphyrin incorporated per vehicle and per area, which had
consequences in the internalization ability of the system and in
the eﬃciency of the porphyrins upon irradiation. We are
currently testing new strategies to formulate the carriers
including the incorporation of recognition ligands to receptors
overexpressed in specic tumour cells to direct the vehicles and
help their internalization by endocytosis.
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